Unpredicted Severe Toxicity after 5-Fluorouracil Treatment due to Dihydropyrimidine Dehydrogenase Deficiency

참고문헌 (21)

1. "Fluoropyrimidine: Cancer chemotherapy and biotherapy. 2nd ed", pp.149~197 (1996), Philadelphia, Lippincott-Raven
2. "Diasio RB. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma", pp.2203~2206 (1987)
3. "Diasio RB. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res 50"
4. "Mirkin BL. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. N Engl J Med 313", pp.245~249 (1985)
5. "Carpenter JT. Familial deficiency of dihydropyrimidine dehydrogenase biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J Clin Invest 81", pp.47~51 (1988)
6. "Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency", 2, pp.477~481 (1996)
7. "Diasio RB. Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency", pp.499~501 (1991)
8. "Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer: status of the art", 30, pp.71~79 (1999)
9. "Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity", 79, pp.627~630 (1999)
10. "Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice", 5, pp.883~889 (1999)
11. "Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase,thymidylate synthase, and thymidine phosphorylase", 6, pp.1322~1327 (2000)
12. "Cha S. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45", pp.5405~5412 (1985)
13. "Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.", 79, pp.620~626 (1999)
14. "Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil", 91, pp.105~112 (2000)
15. "Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression", 39, pp.822~828 (2003)
16. "Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa", 18, pp.705~713 (2001)
17. "Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity", 98, pp.610~615 (1996)
18. "Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene", 6, pp.4705~4712 (2000)
19. "Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil", 41, pp.151~157 (2001)
20. "Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase gene", 14, pp.341~342 (2003)
21. "Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors", 16, pp.3537~3541 (1998)

관련 논문AI추천